Target
Free fatty acid receptor 1
Ligand
BDBM300830
Substrate
n/a
Meas. Tech.
Calcium Flux Assay
EC50
12.0±n/a nM
Citation
 Huang, HKuo, GPlayer, MRYang, SZhang, Y Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes US Patent  US9790198 Publication Date 10/17/2017 
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
  
Inhibitor
Name:
BDBM300830
Synonyms:
2-(1-(4-((3-(4-(1,1-Dioxido-3,6- dihydro-2H-thiopyran-4-yl)-2- methylphenyl)benzo[b]thiophen- 5-yl)methoxy)phenyl)-3- oxocyclobutyl)acetic acid | US10131648, Compound 28 | US10195178, Compound 28 | US9790198, Compound 28
Type:
Small organic molecule
Emp. Form.:
C33H30O6S2
Mol. Mass.:
586.718
SMILES:
Cc1cc(ccc1-c1csc2ccc(COc3ccc(cc3)C3(CC(O)=O)CC(=O)C3)cc12)C1=CCS(=O)(=O)CC1 |t:38|
Structure:
Search PDB for entries with ligand similarity: